| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| CAGR | 5.40 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Substance Abuse Treatment Market Analysis
The Substance Abuse Treatment Market is expected to register a CAGR of 5.4% during the forecast period.
The substance abuse treatment market is expected to grow, driven by increasing drug awareness campaigns, a surge in prevention programs, and a rising number of addiction cases among the population.
The growing consumption of drugs and substances across the world is expected to increase demand for its treatment, thereby boosting the growth of the market during the forecast period. For instance, according to the European Drug Report published in 2023, around 83.4 million adults, accounting for 29% of the European Union's (EU) population aged 15-64, are believed to have experimented with illegal drugs. Notably, cannabis stands out as the predominant illicit substance in Europe. Data from national surveys indicates that approximately 8% of European adults used cannabis in 2022. Thus, a high number of the population consumes drugs, which impacts the lives of individuals and is likely to increase demand for treatment, thereby boosting the segment's growth.
Campaigns and initiatives are heightening awareness about substance abuse treatment among those struggling with addiction, bolstering the market's growth. For instance, in November 2023, The Ad Council, alongside the CDC, National Council for Mental Wellbeing, and Shatterproof, spearheaded the "Start With Hope" campaign. This national public service advertisement (PSA) initiative targets individuals affected by substance use disorders (SUDs), especially Black and Hispanic/Latinx communities. The campaign's primary goal is to instill hope and provide crucial support, emphasizing harm reduction strategies and access to treatment resources for those on the path to recovery. Such a campaign leads to increased awareness of substance abuse treatment, which is anticipated to boost the market's growth during the forecast period.
Moreover, market players' pivotal moves in the substance abuse treatment sector are expected to propel the expansion of the market. For instance, in January 2022, Pfizer Inc. entered a strategic commercial partnership with Alex Therapeutics. The collaboration aims to leverage Alex Therapeutics' AI-based platform for cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT) in treating nicotine addiction.
Therefore, due to rising drug awareness and significant strides made by key market players, the substance abuse treatment market is expected to grow during the analysis period. Additionally, challenges like individual reluctance toward treatment, discontinuation of behavioral therapies, and poor treatment compliance in certain regions are expected to hinder this growth.
Substance Abuse Treatment Market Trends
The Tobacco/Nicotine Addiction Treatment Segment is Expected to Witness Significant Growth During the Forecast Period
The tobacco/nicotine addiction treatment segment is anticipated to witness lucrative growth. Tobacco/nicotine addiction treatment includes pharmacotherapies and replacement therapies to curb the addiction to tobacco and nicotine.
Tobacco and its usage through consumption and smoking are harmful, as they kill half of its users globally, as stated by the World Health Organization (WHO); for instance, in May 2022, the WHO stated that tobacco claimed the lives of more than 8 million people every year. More than 7 million deaths are caused by direct tobacco use, and over 1.2 million non-smokers lose their lives due to exposure to second-hand smoke. Such a vast number of tobacco users and damage caused by tobacco addiction is anticipated to boost the demand for tobacco/nicotine addiction treatment, which would bolster the growth of the segment.
Furthermore, several market players are engaged in advancing their offerings for tobacco/nicotine deaddiction with their smoking cessation therapies and treatments, which are undergoing clinical trials. For instance, in August 2022, Dal Lab, a medical device technology company specializing in smoking cessation, revealed its plans to debut in France, with ambitions to extend its services across Europe, including the United Kingdom. The company is pioneering a novel approach, aiming to introduce the first high-dose electronic nicotine substitute, and this product will be exclusively available in pharmacies, either upon a pharmacist's recommendation or by prescription. Notably, Dal Lab's innovation promises to deliver nicotine replacement without necessitating a shift in smokers' established habits.
Therefore, the tobacco/nicotine addiction treatment segment is expected to witness significant growth during the forecast period due to the abovementioned factors, including the high numbers of tobacco users and the active clinical trials of tobacco/nicotine addiction therapies.
Understand The Key Trends Shaping This Market
Download PDF
North America is Expected to Hold a Significant Market Share During the Forecast Period
The North American substance abuse treatment market is expected to grow significantly during the forecast period with increasing overuse of tobacco and an increasing number of government initiatives aimed at reducing substance abuse. For instance, in September 2022, Quest Diagnostics Drug Testing Index Analysis reported that 7.3% of workers tested with urine drug tests were positive for marijuana in the United States, which is an increase of 9% compared to 2021. Such a prevalent addiction population within the country is anticipated to create more demand for addiction treatments, in turn driving the market's growth in the region.
Furthermore, various initiatives and funding are being implemented by the US government to monitor the symptoms and determine drug abuse among the American population. For instance, as per a February 2022 update, Texas and some of its largest counties received USD 1.17 billion as an opioid relief fund as part of a nationwide settlement from three large pharmaceutical distribution companies. Moreover, in February 2022, the United States Department of Human Health and Services announced a USD 10 million Substance Abuse and Mental Health Services Administration (SAMHSA) grant program addressing the health needs of pregnant women and children affected by substance use. Such programs are anticipated to drive the demand for substance abuse treatment in the United States, thereby driving the market's growth in North America.
Additionally, key developments by the market players in substance abuse treatment are expected to boost the market's growth in the region. For instance, in August 2022, B. More Inc. received USFDA approval for its Investigational New Drug (IND) application for its synthetic psilocybin (SYNP-101), which is intended for the management of alcohol use disorder (AUD). Further, in January 2022, ANANDA Scientific Inc. received USFDA approval for its IND application for the clinical trial evaluation of its drug, Nantheia ATL5. Nantheia ATL5 is an investigational drug that uses cannabidiol (CBD) in ANANDA's proprietary delivery technology and is intended to be used as an adjunctive treatment for opioid use disorder. The study will be done at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at the University of California, Los Angeles, the United States.
Therefore, owing to the aforementioned factors, including the high drug addictions, de-addiction initiatives, and key developments by the key players, the studied market is anticipated to grow further in North America.
Get Analysis on Important Geographic Markets
Download PDF
Substance Abuse Treatment Industry Overview
The substance abuse treatment market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The key players operating in the market are Alkermes PLC, Mallinckrodt LLC, Cipla Ltd, GlaxoSmithKline PLC, and Indivior PLC.
Substance Abuse Treatment Market Leaders
-
Alkermes PLC
-
Mallinckrodt LLC
-
Cipla Ltd
-
GlaxoSmithKline PLC
-
Indivior PLC
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competiters?
Download PDF
Substance Abuse Treatment Market News
- February 2024: The US Department of Health and Human Services (HHS) announced the launch of 2 grant programs through the Substance Abuse and Mental Health Services Administration (SAMHSA) to expand substance use disorder (SUD) treatment services.
- January 2023: Tempero Bio announced FDA clearance of an investigational new drug (IND) application for TMP-301. TMP-301 is an investigational metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM) candidate that is intended for the treatment of cocaine use disorders (CUD).
Substance Abuse Treatment Industry Segmentation
As per the scope of the report, substance abuse refers to the abusive use of psychoactive substances, including illicit drugs, tobacco, and alcohol. Substance abuse treatment helps the patient to rid the body of any drugs and alcohol that are left in the system and reduces drug cravings.
The substance abuse treatment market is segmented by treatment type, distribution channel, and geography. By treatment type, the market is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, drug abuse treatment, and other treatment types. By distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and other distribution channels. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the market size in value terms (USD) for all the abovementioned segments.
| By Treatment Type | Alcohol Addiction Treatment | ||
| Tobacco/Nicotine Addiction Treatment | |||
| Drug Abuse Treatment | |||
| Other Treatment Types | |||
| By Distribution Channel | Hospital Pharmacies | ||
| Retail Pharmacies | |||
| Other Distribution Channels | |||
| Geography | North America | United States | |
| Canada | |||
| Mexico | |||
| Europe | Germany | ||
| United Kingdom | |||
| France | |||
| Italy | |||
| Spain | |||
| Rest of Europe | |||
| Asia-Pacific | China | ||
| Japan | |||
| India | |||
| Australia | |||
| South Korea | |||
| Rest of Asia-Pacific | |||
| Middle East and Africa | GCC | ||
| South Africa | |||
| Rest of Middle East and Africa | |||
| South America | Brazil | ||
| Argentina | |||
| Rest of South America | |||
Need A Different Region or Segment?
Customize Now
Substance Abuse Treatment Market Research FAQs
What is the current Substance Abuse Treatment Market size?
The Substance Abuse Treatment Market is projected to register a CAGR of 5.40% during the forecast period (2025-2030)
Who are the key players in Substance Abuse Treatment Market?
Alkermes PLC, Mallinckrodt LLC, Cipla Ltd, GlaxoSmithKline PLC and Indivior PLC are the major companies operating in the Substance Abuse Treatment Market.
Which is the fastest growing region in Substance Abuse Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Substance Abuse Treatment Market?
In 2025, the North America accounts for the largest market share in Substance Abuse Treatment Market.
What years does this Substance Abuse Treatment Market cover?
The report covers the Substance Abuse Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Substance Abuse Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Substance Abuse Treatment Industry Report
The substance abuse treatment industry is experiencing significant growth, driven by increased awareness of substance abuse's negative impacts and the introduction of new rehabilitation programs worldwide. This expansion is evident across key market segments such as opioids, alcohol, tobacco, and illicit drugs treatments, offered through addiction treatment centers, mental health facilities, hospitals, and community programs. The industry's growth is further propelled by government initiatives, technological advancements in treatments, and a focus on mental health and demographic trends. Despite facing challenges like stigma, regulatory barriers, and workforce shortages, the industry is evolving to meet the complex needs of those struggling with addiction through comprehensive approaches including medication-assisted treatment and both in-patient and out-patient services. According to Mordor Intelligence™ Industry Reports, the substance abuse treatment market is witnessing a notable increase in market share, size, and revenue growth rate, with detailed analysis and forecasts available in their free report PDF download, highlighting the industry's promising outlook amidst challenges.
